본문 바로가기
주메뉴 바로가기
HLBELL
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Hair Cell Therapeutic
Intellectual Property Rights
Pipeline
Development Stage
Product
Hutrigel®-RU
Primary Human Hepatocytes
Primary Animal Hepatocytes
Medical Plastic
PR
Notice
News
Sitemap
Contact
ENG
KOR
ENG
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Hair Cell Therapeutic
Intellectual Property Rights
Pipeline
Development Stage
Product
Hutrigel®-RU
Primary Human Hepatocytes
Primary Animal Hepatocytes
Medical Plastic
PR
Notice
News
SITEMAP
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Hair Cell Therapeutic
Intellectual Property Rights
Pipeline
Development Stage
Product
Hutrigel®-RU
Primary Human Hepatocytes
Primary Animal Hepatocytes
Medical Plastic
PR
Notice
News
PR
Biotech Company Specialized in Regenerative Medicine
News
Notice
News
News
라이프리버, NASH 치료제 美 효능 발표 "1.8조 시장 성큼"
Date 2020.09.04
Hit 1348
기사원문 : https://news.mt.co.kr/mtview.php?no=2016111009095997295&type=1
PREV
라이프리버, 글로벌 바이오기업과 바이오인공간·세포치료제 개발
NEXT
에이치엘비, 바이오그룹으로 도약 속도..라이프리버 가치↑
LIST